Advertisement

Topics

DURECT Release: ORADUR-Methylphenidate ER Capsule Achieves Primary Endpoint In Phase III Study In ADHD In Taiwan

20:00 EDT 7 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: DURECT Release: ORADUR-Methylphenidate ER Capsule Achieves Primary Endpoint In Phase III Study In ADHD In Taiwan

NEXT ARTICLE

More From BioPortfolio on "DURECT Release: ORADUR-Methylphenidate ER Capsule Achieves Primary Endpoint In Phase III Study In ADHD In Taiwan"

Quick Search
Advertisement